Table 3.
Hematoma and PHE Volumes Comparing Patients with Cancer and Controls
| Cancer | Controls | P value | |
|---|---|---|---|
| ICH volume [mL (IQR)] | 9.1 (4.68–15.54) | 10.4 (5.71–19.73) | 0.704 |
| PHE volume [mL (IQR)] | 23.67 (13.16–40.96) | 8.61 (5.93–15.73) | 1.88×10−9 |
| PHE to ICH volume ratio (IQR) | 2.26 (1.69–3.68) | 0.99 (0.79–1.16) | 2.20×10−16 |
| PHE growth [mL (IQR)] | 2.78 (−1.71 to 8.05) | 0.37 (−0.87 to 2.84) | 0.078 |
| ICH growth [mL (IQR)] | 0.955 (−0.25 to 2.58) | 0.54 (−0.52 to 1.10) | 0.105 |
| Time from symptom onset to first scan (h) | 5.3 (2.1–9.9) | 6.1 (2.6–10.5) | 0.922 |
| Time from first to second scan (h) | 11.0 (6.7–17.3) | 12.1 (8.3–18.5) | 0.739 |
ICH indicates intracerebral hemorrhage; mL, milliliters; IQR, interquartile range; PHE, perihematomal edema; and h, hours.